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diastolic threshold with a 200 ms $1-$1 interval to mimic tacby~ttythmlas, 
a 400 ms S2 square wave either with or without a decreasing ramp after the 
square wave was given du.*~; the refractory pedod of the 10th Sl-paced 
AP, followed by $3 and S4 stimuli via the S1 pacing electrode at $1 sVength 
with 200 ms $1.-$3 and $3-$4 intervals. Conduction block was detomllned 
by the fact that $3- and S4-induced APe were recorded near the S~ alto 
(top of Figs.) but not past the $2 site at the other end of the tissue (bottom 
of Figs.). Results: The minimum $2 required to block APs was 3.5 ± 1.2 
mA. $2 at this strength with no ramp caused break excitation (BE, Fig. A). 
When the $2 decreasing ramp interval was increased to 225 4- 88 ms, no 
BE occurred while $3- and S4-induced APs were blocked {Fig. B). Thus, a 
long, weak ramp stimulus given during the refractory padod can block APs 
and not induce BE. 
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This finding raises the possibility that if a long weak stimulus terminated 
by a ramp is applied locally to a reentrant pathway, the .P'Jathway may be 
extinguished without giving rise to a new AP. 
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As studies in animals indicate, atrial det~dllators hould time shocks to be 
beth QRS-synchmneus and delivered following a minimum RR interval, in 
order to avoid the dsk of ventricular pmarrhythmia due to stimulation dudng 
the ventdcular elative refractory pedod. 
This study investigated AF episodes with RR interva~s shorter than a given 
limit (i.e. defibrillator waiting times) in 24-hour Holler tapes recorded dudng 
a cross-over trial of Placebo and Digoxin treatment of pts with paroxysmal 
AE 25 tapes with AF episodes >_ 1003 ventdcular cycles were selected, 
14 of these were recorded on Placebo sod 11 on Digoxin. For each tape, 
the mean and maximum duration of AF episodes with all RR intewals < 
threshold twere measured ranging tfrom 400 to 1000 ms in f0 ms steps. 
The results were averaged for sit Placebo and all Digoxin tapes. The Placebo 
vs. Digoxin values corresponding tO different hresholds were compared by 
a non-parametric U test. 
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The waiting times increased exponentially with the threshold t (note the 
logarithmic scale of the graphs). There were no systematic differences be- 
tWcen mean waiting times (left) on Placebo and Dfgoxln, although Digoxin 
tended to prolong the mean waiting times of t • 700 ms. Them were, how- 
ever, s~ngty algn|flcant differences (p < 10 -4 - 10 -7) between between 
th~ maximum waiting times which were longer with Placebo (dght). 
In paroxysmal AF pts, the waiting time required for a "safe" RR interval 
increases exponentially with the interval selected; technically acceptable 
delays < I minute Correspond to thresholds < 600 ms. Maximum waiting 
times are significantly shortened by Digoxin, 
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A diurnal variation in Implantsble c~rdiovertor defibrillator (ICD) shock fre- 
quency is well described, but seasrnal vacation remains unexplored. 
Aim: This study examines the ~easonal variation in appropriate ICD shock 
trsquency. 
Patients and Methods: All patients who had ICO's implanted at o!.~r inSti- 
tution over the last 6 years had documentation of date of delivery of shock 
therein. The frequency of shock delivery duflng ~e summer months (Apfll to 
September) was comparsd to that during winter months (Octol0er to March). 
Resu~: 86 patients with ICD's (mean age 45 4- 14 years) were followed 
for a moan of 2.5 ± 1,7 years. 45 patients received 321 appropriate shocks 
during this podod, In patients receiving shocks, there was a moan total of 
10,3 shocks dudng winter months in compadaon to 4.9 shocks over summer 
months (p < 0.03). A marked seesonality of shock frequency was observed. 
Winter  8urn  m er  
Condus/ons: Seasonality of lhe occurrence of malignant ventrlc~lar ar- 
rbythmia appears to exist, with a higher frequency in winter months. Factors 
which may thguenca occurrence of malignant ventrlcular arrhythmla over the 
colder winter months remain unexplored. 
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The active can unipoler cardiOverter detibdllator (ICD) has been shown to 
defibrillate fficiently, but the ideal position of the left poctorally implanted e- 
f~dllator device (Can) is unknown. We examined the differences in biphasic 
shock defibrillation thresholds (DFT) achieved at defibrillator implant using 
four different left pocforagy implantation sites: high pectoral medial position 
(A), high pectoral ateral position (B), low pectoral medial position ((3) and 
low pectoral lateral position (D). DFTs at implant were tested using a step 
down pretocol, The study population comprised of 60 patients (mean age 
60 4- 11 years; 51 m/9 f). The presenting rhythm was VF in 29 and V'I" in 
31 patients. Undedying Ischemic heart disease was present in 39, idiopathic 
cardiomyopathy in 17, and valvular heart disease in 4 park.ors. (LVEF 39 ± 
14"/o). 
Resuks: No d~leronces were observed between these groups regarding 
age, gender, organic heart disease, LVEF, and antiarrhythmic drugs dudng 
DFT-tasting, 
Position A Position B Position C Position D 
No. of ple 12 18 16 15 
DFT (J) 11.6 -~ 3.3 12.5:1:3.7 7.5 -4- 2.3* 16.9 4. 5.1 * 
• p < 0.05 
Conclusion: 1. Low defibrillation thresholds with pectorelly implanted ICP~ 
are achieved regardless of the implantation site of the active can, 2. The best 
position seemed to be the low pectoral medial region. 3. The DFT was about 
50--100% higher in the 3 other pectoral positions. 
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Although the problem of ICD sensing of paced vantrlcular stimuli has been 
rPsolvod by incorporation of WI pacing into current ICDs, many pts require 
~eparato DDD pacomakem (PMs) f~r maintenance of AV synchmny. We 
report a problematic PM-ICD Interaction: inability to prevent sensing of paced 
atrial stimuli (a-senolng) leading to doubts-counting In PM-requiring pts with 
transvenous (TV) ICDs with e,Y ' ,~ autogaln sensing (Ventak PRx2 or 
3). In 7 pts (6 M, 1 F; mean a~,, ';-, mean EF 29%; 6 CAD, 1 CM), a TV 
DDD PM was implanted following (6) or concomitantly with (1) a "IV ICD. 
indications for pacing: heart block (liB) (6 pts), sinus brady (1). 
Results: All 710is had CPI Endotak leads at the RV apex. 4/7 pts had a- 
senslng, leading to double counting, despite intra--operattvs testing of multiple 
atrial locations with an active-tixatton lead. No pt had sensing of ventdcular 
stimuli, with all PM leads positioned on the RV septum. 6 pts had a PRx2/3 
ICD, 4 with s-sensing (66%), and 1 a PRx, without a-sensing. Pts with a- 
sensing were not distinguished by measured I~ or P waves, atrial threshold, 
type of atrial lead, or RA size. In all pts with a-sensing, (all HB) double- 
Counting was avoided by programming the PM to VDD mode. No pt has 
received Inappropriate herapy or failed to sense VF in follow-up. 
